Researchers discover molecule involved in the repair of liver wounds

September 26, 2018, Instituto Gulbenkian de Ciencia
Comparison between healthy hepatic tissue (left) and tissue with wounds (right). Credit: Nádia Duarte, IGC.

A new study from researchers of CEDOC-NOVA Medical School|Faculdade de Ciências Médicas and Instituto Gulbenkian de Ciência, led by Maria Paula Macedo and Carlos Penha-Gonçalves, respectively, showed that a molecule CD26/DPP-4 is involved in the regeneration of acute liver wounds and is a promising biomarker for hepatic disease. The results are published in Hepatology Communications

It is known that DPP-4 regulates insulin secretion upon food intake. The regulation of the levels of sugar in the blood in type 2 diabetics is performed by therapeutic inhibition of of the molecule CD26/DPP-4. This approach has clinical relevance. Moreover, apart from its role in the control of the amount of sugar present in blood, the molecule DPP4 appears to be related with inflammatory reactions in various pathological processes.

In this study, the researchers explored the role of CD26/DPP-4 during injury of the hepatic tissue leading to evident reduction of the main liver immune (Kupffer ). It was shown that the blood levels of CD26/DPP-4 enzymatic activity are augmented when this population of liver immune cells is diminished, both in acute and chronic mouse models of liver injury. Inversely, the levels of blood enzymatic activity decreased during recovery of these cells. The authors observed that specific deletion of such immune liver cell population in absence of liver tissue damage also lead to significant increase in CD26/DPP4 blood enzymatic activity. Thus, these results show the close relation between functional changes in Kupffer cells associated with hepatic diseases and the molecule CD26/DPP-4.

The relation between the liver immune cells and the enzymatic activity of CD26/DPP-4 in the blood, exhibited in this study, suggests that the level/amount of the enzymatic activity of the molecule CD26/DPP-4 in the might be used as a biomarker. Moreover, it can become a valuable biochemical parameter for the evaluation of hepatic lesion or disorder since so far can this evaluation can only be performed using invasive techniques.

Explore further: Muscular dystrophy clue

More information: Nádia Duarte et al, Dipeptidyl Peptidase-4 Is a Pro-Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells, Hepatology Communications (2018). DOI: 10.1002/hep4.1225

Related Stories

Muscular dystrophy clue

February 12, 2018
Patients with Duchenne muscular dystrophy (DMD) have a genetic mutation that causes incurable muscle degeneration. Research has shown that the immune system plays a complex, double-sided role in muscular dystrophy—promoting ...

Hepatic fat accumulation may have causal role in liver disease

January 11, 2018
(HealthDay)—Hepatic fat accumulation may play a causal role in chronic liver disease, according to a study published online Dec. 27 in the Journal of Internal Medicine.

Overlooked immune cells hold breakthrough for treating aggressive cancers

December 20, 2017
The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat the disease. Like Dorothy in "The Wizard of Oz," what research teams around the world have spent decades searching ...

Hepatitis therapy: Kupffer cells adjust the balance between pathogen control and hepatocyte regenera

January 17, 2018
Inflammation of the liver can result from different causes. Besides infections with hepatitis B virus (HBV) and hepatitis C virus (HCV), other viruses such as cytomegalovirus (CMV) are able to trigger acute hepatitis. Sometimes ...

Molecule's role in maintaining liver size and function revealed

August 1, 2017
For organs to maintain a steady state and fulfill their intended functions, the rates at which the cells within them multiply or die off need to be equal. This balance must also be adjusted when events such as an injury or ...

Stellate cells in the liver control regeneration and fibrosis

February 24, 2015
Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem. An estimated ten percent of the population is affected by liver fibrosis or its corresponding later stage, liver ...

Recommended for you

Scientists shed new light on infection process of the gastrointestinal pathogen C. difficile

November 21, 2018
Scientists from the VIB-UGent Center for Inflammation Research identified the mechanisms by which the bacterial pathogen Clostridium difficile kills intestinal epithelial cells (IECs), thus destroying the protective mucosal ...

As antibiotic resistance grows, researchers find new targets for fighting deadly staph infections

November 21, 2018
A new look at the inner-workings of bacterial cells could help researchers overcome deadly antibiotic resistance and save the lives of tens-of-thousands of people every year.

Can liver disease be linked to heart failure? Study highlights liver-heart interaction

November 21, 2018
Virginia Commonwealth University researchers have collaborated on a clinical trial that identifies indicators for nonalcoholic fatty liver disease—a typically asymptomatic disease caused by fat buildup in the liver and ...

Researchers find infectious prions throughout eyes of patients with deadly sporadic Creutzfeldt-Jakob disease

November 20, 2018
By the time symptoms of sporadic Creutzfeldt-Jakob disease (sCJD) are typically discovered, death is looming and inevitable. But, in a new study, researchers at University of California San Diego School of Medicine with colleagues ...

Researchers a step closer to understanding how deadly bird flu virus takes hold in humans

November 19, 2018
New research has taken a step towards understanding how highly pathogenic influenza viruses such as deadly bird flu infect humans.

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.